ELV Earnings Date: Jan 27, 2027 (Estimated) — Elevance Health Inc.
NYSE · Healthcare · Healthcare Plans
Updated
When is ELV's next earnings date?
Elevance Health Inc. (ELV) is expected to report Q4 2026 earnings on Wednesday, January 27, 2027 at 6:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $2.50 on revenue of $48.04B.
How did ELV do in its last earnings report?
In its most recent report on Oct 21, 2026, Elevance Health Inc. posted EPS of $6.99 versus the $4.66 estimate, a beat of 50.0%. Revenue was $50.44B against a $49.30B estimate. The stock's 1-day post-earnings move was +1.2%.
How much does ELV stock move after earnings?
ELV beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.0% (up or down) in the day after earnings.
About Elevance Health Inc.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
🤖 AI Earnings Analysis
Elevance’s Q3 beat and raised full-year guidance signal stronger execution in managed care, but results are mixed: $50.4B revenue topped estimates while reported growth is distorted and operating margin is only 2.8%.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-21 | 4.66 | 6.99 | +50.00% | $50.44B | ✅ Beat | +1.16% | -4.25% | — | |
| 2026-07-15 | Q2 2026 | 6.20 | 7.45 | +20.16% | $49.83B | ✅ Beat | -8.54% | -7.82% | -6.48% |
| 2026-04-22 | Q1 2026 | 10.74 | 12.58 | +17.13% | $49.49B | ✅ Beat | +0.03% | +10.55% | +20.76% |
| 2026-01-28 | Q4 2025 | 3.10 | 3.33 | +7.42% | $49.31B | ✅ Beat | +5.86% | +4.87% | +0.04% |
| 2025-10-21 | Q3 2025 | 4.96 | 6.03 | +21.57% | $50.09B | ✅ Beat | -1.22% | -3.27% | -8.34% |
| 2025-04-22 | Q1 2025 | 11.38 | 11.97 | +5.18% | $48.77B | ✅ Beat | +2.26% | +1.75% | +1.43% |
| 2025-01-23 | Q4 2024 | 3.86 | 3.84 | -0.52% | $44.99B | ❌ Miss | +2.72% | +2.45% | -1.44% |
| 2024-10-17 | Q3 2024 | 9.66 | 8.37 | -13.35% | $44.72B | ❌ Miss | -10.59% | -16.38% | -18.09% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q3 FY26 · $62.66B total
| Segment | Share | Revenue | YoY | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|
| Health Benefits | 69.2% | $43.36B | +2.6% | $41.43B | $41.58B | $42.25B | $41.84B |
| Carelon Services | 30.8% | $19.31B | +5.4% | $16.65B | $18.08B | $18.32B | $18.66B |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.